ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 193 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q2 2020. The put-call ratio across all filers is 0.60 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $26,676,111 | -4.3% | 748,278 | +23.8% | 0.16% | -1.9% |
| Q2 2023 | $27,875,759 | -10.4% | 604,287 | -22.1% | 0.16% | -15.7% |
| Q1 2023 | $31,108,578 | +1.6% | 775,775 | +17.3% | 0.19% | -7.7% |
| Q4 2022 | $30,627,976 | +234.8% | 661,083 | +199.3% | 0.21% | +187.5% |
| Q3 2022 | $9,147,000 | +3679.8% | 220,880 | +7580.1% | 0.07% | +3500.0% |
| Q4 2021 | $242,000 | -75.3% | 2,876 | -75.8% | 0.00% | -80.0% |
| Q3 2020 | $978,000 | -53.4% | 11,898 | -55.6% | 0.01% | -56.5% |
| Q2 2020 | $2,097,000 | +383.2% | 26,806 | +174.2% | 0.02% | +283.3% |
| Q1 2020 | $434,000 | +80.1% | 9,777 | +106.7% | 0.01% | +50.0% |
| Q1 2018 | $241,000 | – | 4,730 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| First Light Asset Management, LLC | 213,887 | $29,608,000 | 2.19% |
| Rock Springs Capital Management LP | 566,500 | $78,421,000 | 1.66% |
| FEDERATED HERMES, INC. | 4,280,528 | $592,554,000 | 1.21% |
| AtonRa Partners | 17,646 | $2,443,000 | 1.20% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 218,390 | $30,232,000 | 1.05% |
| EMERALD ADVISERS, LLC | 226,875 | $31,406,000 | 1.04% |
| Atika Capital Management LLC | 89,000 | $12,319,000 | 0.96% |
| Capital Impact Advisors, LLC | 25,582 | $3,541,000 | 0.87% |
| JGP Global Gestao de Recursos Ltda. | 1,586 | $220,000 | 0.83% |
| CAPITAL INTERNATIONAL LTD /CA/ | 79,742 | $11,039,000 | 0.64% |